Epharm Laboratories products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer with more than two decades of operations, a broad registered portfolio and domestic and international market ambitions.
Epharm Laboratories products in Pakistan
Epharm Laboratories has 144 medicine presentations registered in Pakistan under 75 brands, covering 67 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Keley (Cephalexin), Teltan (Telmisartan + Hydrochlorothiazide), Astron (Moxifloxacin) and Epan (Cefixime). 144 products have an official DRAP price on MedInfoBase. See all 75 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- A-40, Road No. 1, S.I.T.E. Super Highway Industrial Area, North Karachi, Karachi 75340, Pakistan · 75340
- Website
- epharmlaboratories.com ↗
- Phone
- +92 300 0268033
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Epharm Laboratories is priced against the market
131 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Algixim | Cefotaxime | 250 mg | IM/IV injection | 1 Vial | 047490 | PKR 97.08 | PKR 97.08/vial/unit | 🔒 Pharma Pro |
| Algixim | Cefotaxime | 500 mg | Injection | 1 Vial | 047491 | PKR 168.48 | PKR 168.48/vial/unit | 🔒 Pharma Pro |
| Algixim | Cefotaxime | 1 g | Injection | 1 Vial | 047492 | PKR 297.32 | PKR 297.32/vial/unit | 🔒 Pharma Pro |
| Anibret | Terbinafine | 125 mg | Tablet | 10's | 104340 | PKR 447.60 | PKR 44.76/tablet | 🔒 Pharma Pro |
| Anibret | Terbinafine | 250 mg | Tablet | 10's | 104341 | PKR 715.02 | PKR 71.50/tablet | 🔒 Pharma Pro |
| Anibret | Terbinafine | 1 % | Cream | 10gm | 104342 | PKR 252.11 | PKR 25.21/g | 🔒 Pharma Pro |
| Astron | Moxifloxacin | 5 mg/mL | Ophthalmic drops | 1x5ml | 070818 | PKR 342.35 | PKR 68.47/mL | No comparator |
| Astron | Moxifloxacin | 5 mg/mL | Ophthalmic drops | 1x3ml | 070818 | PKR 237.74 | PKR 79.25/mL | No comparator |
| Astron | Moxifloxacin | 400 mg | Tablet | 5's | 076351 | PKR 873.67 | PKR 174.73/tablet | 🔒 Pharma Pro |
| Astron | Moxifloxacin | 400 mg/250 mL | IV infusion | 250ml (Vial) | 112722 | PKR 1,258.10 | PKR 5.03/mL | 🔒 Pharma Pro |
| Atenopharm | Atenolol | 100 mg | Tablet | 20's | 061890 | PKR 190.19 | PKR 9.51/tablet | 🔒 Pharma Pro |
| Atenopharm | Atenolol | 50 mg | Tablet | 20's | 061893 | PKR 140.74 | PKR 7.04/tablet | 🔒 Pharma Pro |
| Atenopharm | Atenolol | 25 mg | Tablet | 2x10's | 061902 | PKR 99.03 | PKR 4.95/tablet | 🔒 Pharma Pro |
| Atorpharm | Atorvastatin | 20 mg | Tablet | 10’s | 089202 | PKR 418.43 | PKR 41.84/tablet | 🔒 Pharma Pro |
| Atorpharm | Atorvastatin | 10 mg | Tablet | 10’s | 089206 | PKR 247.25 | PKR 24.73/tablet | 🔒 Pharma Pro |
| Autoben | Albendazole | 200 mg | Tablet | 10's | 104098 | PKR 117.05 | PKR 11.71/tablet | 🔒 Pharma Pro |
| Autoben | Albendazole | 200 mg | Tablet | 2's | 104098 | PKR 25.51 | PKR 12.76/tablet | 🔒 Pharma Pro |
| Avlochlor-HS | Hydroxychloroquine | 200 mg | Tablet | 5x10's | 104316 | PKR 675.31 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Avlochlor-HS | Hydroxychloroquine | 200 mg | Tablet | 30's | 104316 | PKR 405.18 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Avlochlor-P | Chloroquine | 250 mg | Tablet | 50x10's | 104317 | PKR 637.76 | PKR 1.28/tablet | 🔒 Pharma Pro |
| Avlochlor-P | Chloroquine | 50 mg/5 mL | Syrup | 60ml | 104318 | PKR 21.22 | PKR 0.35/mL | 🔒 Pharma Pro |
| Betnopharm | Betamethasone valerate | 1 mg/g (0.1%) | Ointment | 15gm | 092764 | PKR 67.82 | PKR 4.52/g | 🔒 Pharma Pro |
| Betnopharm | Betamethasone valerate | 1 mg/g (0.1%) | Ointment | 5gm | 092764 | PKR 22.98 | PKR 4.60/g | 🔒 Pharma Pro |
| Betol | Timolol | 0.5 % | Ophthalmic solution | 5ml | 073456 | PKR 174.74 | PKR 34.95/mL | No comparator |
| Bisadyl | Bisacodyl | 5 mg | Tablet | 10x10’s | 089209 | PKR 67.30 | PKR 0.67/tablet | 🔒 Pharma Pro |
| Buscopharm | Hyoscine butylbromide | 20 mg/mL | Injection | 30's | 044158 | PKR 288.20 | PKR 9.61/vial/unit | No comparator |
| Cadlizo | Linezolid | 400 mg | Tablet | 12's | 104238 | PKR 2,190.99 | PKR 182.58/tablet | 🔒 Pharma Pro |
| Cadlizo | Linezolid | 600 mg | Tablet | 12's | 104239 | PKR 3,835.74 | PKR 319.65/tablet | 🔒 Pharma Pro |
| Ceftin | Cefuroxime | 125 mg/5 mL | Suspension | 60ml | 083336 | PKR 388.35 | PKR 6.47/mL | 🔒 Pharma Pro |
| Ceftin | Cefuroxime | 250 mg | Injection | 1's | 083957 | PKR 54.35 | PKR 54.35/vial/unit | 🔒 Pharma Pro |
| Ceftin | Cefuroxime | 750 mg | Injection | 1's | 083958 | PKR 194.15 | PKR 194.15/vial/unit | 🔒 Pharma Pro |
| Citazest | Metformin | 850 mg | Tablet | 50's | 112728 | PKR 224.55 | PKR 4.49/tablet | 🔒 Pharma Pro |
| Citazest | Metformin | 500 mg | Tablet | 5x10's | 128002 | PKR 79.62 | PKR 1.59/tablet | 🔒 Pharma Pro |
| Conate | Clotrimazole | 1 % | Cream | 15gm | 120160 | PKR 48.07 | PKR 3.20/g | 🔒 Pharma Pro |
| Conate s | Clotrimazole | 0.5 g | Vaginal tablet | 1's | 110350 | PKR 90.41 | PKR 90.41/tablet | No comparator |
| Conate-HC CreamRegistry verified | Clotrimazole, Hydrocortisone (as acetate) | — | — | — | 110354Official source ↗ | No indexed price | — | — |
| Cozole | Fluconazole | 150 mg | Capsule | 1's | 073459 | PKR 267.92 | PKR 267.92/capsule | 🔒 Pharma Pro |
| D.Dron | Dexamethasone | 4 mg/mL | Injection | 1mlx25's | 058424 | PKR 455.23 | PKR 18.21/mL | 🔒 Pharma Pro |
| Dxcyne | Doxycycline | 100 mg | Capsule | 10x10's | 076356 | PKR 757.17 | PKR 7.57/capsule | 🔒 Pharma Pro |
| Ekasin | Amikacin | 500 mg/2 mL | Injection | 2mlx1's | 081055 | PKR 242.69 | PKR 121.35/mL | 🔒 Pharma Pro |
| Ekasin | Amikacin | 100 mg/2 mL | Injection | 2mlx1's | 081056 | PKR 79.60 | PKR 39.80/mL | 🔒 Pharma Pro |
| Emycin | Azithromycin | 250 mg | Capsule | 10's | 083959 | PKR 495.07 | PKR 49.51/capsule | 🔒 Pharma Pro |
| Epan | Cefixime | 400 mg | Capsule | 1x5's | 044173 | PKR 388.29 | PKR 77.66/capsule | 🔒 Pharma Pro |
| Epan | Cefixime | 100 mg/5 mL | Suspension | 30ml | 044174 | PKR 194.14 | PKR 6.47/mL | 🔒 Pharma Pro |
| Epan | Cefixime | 100 mg/5 mL | Suspension | 60ml | 044174 | PKR 368.89 | PKR 6.15/mL | 🔒 Pharma Pro |
| Epan | Cefixime | 200 mg | Capsule | 5's | 070503 | PKR 232.98 | PKR 46.60/capsule | 🔒 Pharma Pro |
| Epan-DS | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 070502 | PKR 404.31 | PKR 13.48/mL | 🔒 Pharma Pro |
| Ephacard | Amlodipine | 5 mg | Tablet | 2x10’s | 089349 | PKR 193.89 | PKR 9.69/tablet | 🔒 Pharma Pro |
| Ephagent | Gentamicin | 40 mg/mL | Injection | 2mlx25's | 044163 | PKR 592.71 | PKR 11.85/mL | 🔒 Pharma Pro |
| Ephagent | Gentamicin | 40 mg/mL | Injection | 2mlx5's | 044163 | PKR 122.26 | PKR 12.23/mL | 🔒 Pharma Pro |
All 75 Epharm Laboratories brands in Pakistan
- Algixim Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Anibret Terbinafine · 1 % cream, 125 mg tablet, 250 mg tablet
- Astron Moxifloxacin · 400 mg tablet, 400 mg/250 mL infusion, 5 mg/mL drops
- Atenopharm Atenolol · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Atorpharm Atorvastatin · 10 mg tablet, 20 mg tablet
- Autoben Albendazole · 200 mg tablet
- Avlochlor-HS Hydroxychloroquine · 200 mg tablet
- Avlochlor-P Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
- Betnopharm Betamethasone valerate · 1 mg/g (0.1%) ointment
- Betol Timolol · 0.5 % solution
- Bisadyl Bisacodyl · 5 mg tablet
- Buscopharm Hyoscine butylbromide · 20 mg/mL injection
- Cadlizo Linezolid · 400 mg tablet, 600 mg tablet
- Ceftin Cefuroxime · 125 mg/5 mL suspension, 250 mg injection, 750 mg injection
- Citazest Metformin · 500 mg tablet, 850 mg tablet
- Conate Clotrimazole · 1 % cream
- Conate s Clotrimazole · 0.5 g pessary
- Cozole Fluconazole · 150 mg capsule
- D.Dron Dexamethasone · 4 mg/mL injection
- Dxcyne Doxycycline · 100 mg capsule
- Ekasin Amikacin · 100 mg/2 mL injection, 500 mg/2 mL injection
- Emycin Azithromycin · 250 mg capsule
- Epan Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
- Epan-DS Cefixime · 200 mg/5 mL suspension
- Ephacard Amlodipine · 5 mg tablet
- Ephagent Gentamicin · 40 mg/mL injection
- Ephagent Eye and Ear Gentamicin · 0.3 g/100 mL drops
- Ephamic Tranexamic acid · 250 mg/5 mL injection, 500 mg capsule
- Ephamide Furosemide · 20 mg/2 mL injection
- Ephasaline Nasal Sodium chloride · 0.65 % drops
- Ephtum Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Eptrim Artemether · 20 mg/mL injection, 40 mg/mL injection, 80 mg/mL injection
- Eptrim-DS 40 Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Eptrim-M 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Eptrim-X 80 Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Ethanzap-10 Olanzapine · 10 mg tablet
- Ethanzap-5 Olanzapine · 5 mg tablet
- Faremicin Fosfomycin · 500 mg capsule
- Feofar Letrozole · 2.5 mg tablet
- Fledore Fluoxetine · 20 mg capsule
- Flociprin Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 500 mg tablet
- Follinemic Elemental Iron · 40 mg/15 mL syrup
- Frutcee Chewable Ascorbic acid · 500 mg tablet
- Iropharm Elemental Iron · 100 mg tablet, 50 mg/5 mL syrup
- Iropharm-F Iron + Folic acid · 100 mg + 0.35 mg tablet, 50 mg/5 mL + 0.35 mg/5 mL syrup
- IT Itraconazole · 100 mg capsule
- Izmepra Omeprazole · 20 mg capsule, 40 mg capsule
- Keley Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Klath Clarithromycin · 250 mg tablet, 500 mg tablet
- L-Tan Losartan · 50 mg tablet
- Lacnan Lactulose · 3.35 g/5 mL syrup
- Levopharm Levofloxacin · 250 mg tablet, 500 mg tablet, 500 mg/100 mL infusion
- Lignopharm Lidocaine · 1 % injection, 2% gel
- Lopidrel Clopidogrel · 75 mg tablet
- Loratlax Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Mazitrom Azithromycin · 250 mg tablet, 500 mg tablet
- Methpharm Permethrin · 50 mg/g cream
- Midrozole Miconazole · 2 % gel
- Nystapharm Nystatin · 100,000 units/mL drops
- O-Mide Loperamide HCl · 2 mg capsule
- Oxy Tetracycline · 250 mg capsule
- PC-Trax Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Reneph Ranitidine · 150 mg tablet, 50 mg/2 mL injection
- Ribapharm Ribavirin · 500 mg tablet, 600 mg tablet
- Seltaferon Oseltamivir · 12 mg/mL suspension, 75 mg capsule
- Silvopharm Silver sulfadiazine · 1 % cream
- Synthivan Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Taripharm Ofloxacin · 0.3 % drops, 200 mg tablet, 200 mg/100 mL infusion
- Teltan Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- Tropix Tropicamide · 1 % drops
- Valenfer Iron · 100 mg/5 mL injection
- Ventopharm Salbutamol · 2 mg tablet, 4 mg tablet
- Vomilide Metoclopramide · 10 mg tablet, 10 mg/2 mL injection, 5 mg/5 mL solution
- Zonapril Lisinopril · 10 mg tablet, 20 mg tablet, 5 mg tablet
- Zuplenz Ondansetron · 8 mg/4 mL injection
Epharm Laboratories: common questions
How many products does Epharm Laboratories have in Pakistan?
Epharm Laboratories has 144 registered medicine presentations in Pakistan, sold under 75 brands and covering 67 generic medicines.
What are the main brands of Epharm Laboratories?
By number of registered strengths and packs, its largest brands are Keley (Cephalexin), Teltan (Telmisartan + Hydrochlorothiazide), Astron (Moxifloxacin), Epan (Cefixime) and Flociprin (Ciprofloxacin). This is not a sales ranking.
Which therapy areas does Epharm Laboratories cover?
The most products are in Anti-infectives (82), Cardiovascular (17), Gastrointestinal & hepatology (13), Vitamins, minerals & nutrition (9) and Hematology & thrombosis (4).
Where can I see Epharm Laboratories medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.